{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:02:19Z","timestamp":1766268139024},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,26]]},"DOI":"10.7759\/cureus.40976","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T15:23:32Z","timestamp":1687793012000},"source":"Crossref","is-referenced-by-count":3,"title":["Association Between Pulmonary Hypertension and Its Effect on 30-Day Mortality, Readmission, and Cost After Transcatheter Aortic Valve Replacement: A Multicenter Study"],"prefix":"10.7759","author":[{"given":"Mansoor","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Del Cid Fratti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mena","family":"Henien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailash","family":"Pant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew  P","family":"Wattelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Whorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett C","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minchul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Barzallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Mungee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper MM","year":"2016","unstructured":"Hoeper MM, Humbert M, Souza R, et al.. A global view of pulmonary hypertension. Lancet Respir Med. 2016, 4:306-22. 10.1016\/s2213-2600(15)00543-3","journal-title":"Lancet Respir Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.11.031","article-title":"Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis","volume":"107","author":"Ben-Dor I","year":"2011","unstructured":"Ben-Dor I, Goldstein SA, Pichard AD, et al.. Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis. Am J Cardiol. 2011, 107:1046-51. 10.1016\/j.amjcard.2010.11.031","journal-title":"Am J Cardiol"},{"key":"ref3","article-title":"Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study","volume":"21","author":"Burke JP","year":"2015","unstructured":"Burke JP, Hunsche E, R\u00e9gulier E, Nagao M, Buzinec P, Drake Iii W. Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study. Am J Manag Care. 2015, 21:s47-58.","journal-title":"Am J Manag Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.6.608","article-title":"The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States","volume":"28","author":"Ogbomo A","year":"2022","unstructured":"Ogbomo A, Tsang Y, Mallampati R, Panjabi S. The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States. J Manag Care Spec Pharm. 2022, 28:608-16. 10.18553\/jmcp.2022.28.6.608","journal-title":"J Manag Care Spec Pharm"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.02.015","article-title":"Pulmonary hypertension in patients with\u00a0severe aortic stenosis: prognostic\u00a0impact after transcatheter\u00a0aortic valve replacement: pulmonary hypertension in patients undergoing TAVR","volume":"12","author":"Alushi B","year":"2019","unstructured":"Alushi B, Beckhoff F, Leistner D, et al.. Pulmonary hypertension in patients with\u00a0severe aortic stenosis: prognostic\u00a0impact after transcatheter\u00a0aortic valve replacement: pulmonary hypertension in patients undergoing TAVR. JACC Cardiovasc Imaging. 2019, 12:591-601. 10.1016\/j.jcmg.2018.02.015","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308001","article-title":"Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement","volume":"101","author":"Lindman BR","year":"2015","unstructured":"Lindman BR, Zajarias A, Maniar HS, et al.. Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement. Heart. 2015, 101:1656-64. 10.1136\/heartjnl-2015-308001","journal-title":"Heart"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.002358","article-title":"Effect of pulmonary hypertension hemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve implantation: insights from the new proposed pulmonary hypertension classification","volume":"8","author":"O'Sullivan CJ","year":"2015","unstructured":"O'Sullivan CJ, Wenaweser P, Ceylan O, et al.. Effect of pulmonary hypertension hemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve implantation: insights from the new proposed pulmonary hypertension classification. Circ Cardiovasc Interv. 2015, 8:e002358. 10.1161\/CIRCINTERVENTIONS.114.002358","journal-title":"Circ Cardiovasc Interv"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(99)00643-8","article-title":"Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis","volume":"85","author":"Faggiano P","year":"2000","unstructured":"Faggiano P, Antonini-Canterin F, Ribichini F, et al.. Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. Am J Cardiol. 2000, 85:204-8. 10.1016\/s0002-9149(99)00643-8","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.03.014","article-title":"A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement","volume":"113","author":"Capodanno D","year":"2014","unstructured":"Capodanno D, Barbanti M, Tamburino C, et al.. A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol. 2014, 113:1851-8. 10.1016\/j.amjcard.2014.03.014","journal-title":"Am J Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.08.019","article-title":"Prognostic impact of pulmonary artery systolic pressure in patients undergoing transcatheter aortic valve replacement for aortic stenosis","volume":"114","author":"Bishu K","year":"2014","unstructured":"Bishu K, Suri RM, Nkomo VT, et al.. Prognostic impact of pulmonary artery systolic pressure in patients undergoing transcatheter aortic valve replacement for aortic stenosis. Am J Cardiol. 2014, 114:1562-7. 10.1016\/j.amjcard.2014.08.019","journal-title":"Am J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.113.000482","article-title":"Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 Registry","volume":"7","author":"Lu\u00e7on A","year":"2014","unstructured":"Lu\u00e7on A, Oger E, Bedossa M, et al.. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 Registry. Circ Cardiovasc Interv. 2014, 7:240-7. 10.1161\/CIRCINTERVENTIONS.113.000482","journal-title":"Circ Cardiovasc Interv"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.08.757","article-title":"Impact of periprocedural pulmonary hypertension on outcomes after transcatheter aortic valve replacement","volume":"80","author":"Miyamoto J","year":"2022","unstructured":"Miyamoto J, Ohno Y, Kamioka N, et al.. Impact of periprocedural pulmonary hypertension on outcomes after transcatheter aortic valve replacement. J Am Coll Cardiol. 2022, 80:1601-13. 10.1016\/j.jacc.2022.08.757","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.002253","article-title":"Pulmonary hypertension in patients undergoing transcatheter aortic valve replacement: discussion of the current evidence","volume":"8","author":"G\u00f6ssl M","year":"2015","unstructured":"G\u00f6ssl M, Kane GC, Mauermann W, Holmes DR. Pulmonary hypertension in patients undergoing transcatheter aortic valve replacement: discussion of the current evidence. Circ Cardiovasc Interv. 2015, 8:e002253. 10.1161\/CIRCINTERVENTIONS.114.002253","journal-title":"Circ Cardiovasc Interv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(02)02002-8","article-title":"Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications","volume":"4","author":"Malouf J","year":"2002","unstructured":"Malouf J, Enriquez-Sarano M, Pellikka P, et al.. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J Am Coll Cardiol. 2002, 4:789-95. 10.1016\/s0735-1097(02)02002-8","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(90)90095-n","article-title":"Reversibility of pulmonary artery hypertension in aortic stenosis after aortic valve replacement","volume":"50","author":"Tracy GP","year":"1990","unstructured":"Tracy GP, Proctor MS, Hizny CS, et al.. Reversibility of pulmonary artery hypertension in aortic stenosis after aortic valve replacement. Ann Thorac Surg. 1990, 50:89-93. 10.1016\/0003-4975(90)90095-n","journal-title":"Ann Thorac Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/163395-association-between-pulmonary-hypertension-and-its-effect-on-30-day-mortality-readmission-and-cost-after-transcatheter-aortic-valve-replacement-a-multicenter-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:09Z","timestamp":1707509229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/163395-association-between-pulmonary-hypertension-and-its-effect-on-30-day-mortality-readmission-and-cost-after-transcatheter-aortic-valve-replacement-a-multicenter-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.40976","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,26]]}}}